StockData
Xencor Inc logo

Xencor Inc (XNCR) stock

XNCRNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 5/30194% above fair value
$34.39−0.11 (-0.32%)

Close on Nov 18, 2026Market cap $2.56BP/E –Yield –

Xencor operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

Xencor's operating cash flow for the twelve months ending Jun 30, 2026 was -$205.81M. For fiscal 2025 it was -$135.12M. The highest annual figure on record is $95.24M in fiscal 2016.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$135.12M–
FY2024Dec 31, 2024-$202.19M–
FY2023Dec 31, 2023-$77.93M-418.3%
FY2022Dec 31, 2022$24.49M–
FY2021Dec 31, 2021-$16.85M–
FY2020Dec 31, 2020-$5.00M-107.8%
FY2019Dec 31, 2019$64.37M–
FY2018Dec 31, 2018-$79.76M–
FY2017Dec 31, 2017-$33.60M-135.3%
FY2016Dec 31, 2016$95.24M+257.2%
FY2015Dec 31, 2015$26.67M–
FY2014Dec 31, 2014-$21.35M–
FY2013Dec 31, 2013-$5.45M–
FY2012Dec 31, 2012-$11.05M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$55.66M–
Q1 FY2026Mar 31, 2026-$67.63M–
Q4 FY2025Dec 31, 2025-$51.71M–
Q3 FY2025Sep 30, 2025-$30.82M–
Q2 FY2025Jun 30, 2025-$36.37M–
Q1 FY2025Mar 31, 2025-$16.22M–
Q4 FY2024Dec 31, 2024-$49.84M-374.3%
Q3 FY2024Sep 30, 2024-$28.14M–
Q2 FY2024Jun 30, 2024-$67.35M–
Q1 FY2024Mar 31, 2024-$56.86M–
Q4 FY2023Dec 31, 2023$18.17M–
Q3 FY2023Sep 30, 2023-$27.28M–
Q2 FY2023Jun 30, 2023-$38.20M-186.3%
Q1 FY2023Mar 31, 2023-$30.61M-626.5%
Q4 FY2022Dec 31, 2022-$24.43M-139.5%
Q3 FY2022Sep 30, 2022-$1.17M–
Q2 FY2022Jun 30, 2022$44.27M–
Q1 FY2022Mar 31, 2022$5.82M–
Q4 FY2021Dec 31, 2021$61.79M+261.7%
Q3 FY2021Sep 30, 2021-$39.02M–
Q2 FY2021Jun 30, 2021-$9.65M–
Q1 FY2021Mar 31, 2021-$29.97M-416.8%
Q4 FY2020Dec 31, 2020$17.08M–
Q3 FY2020Sep 30, 2020-$3.87M–
Q2 FY2020Jun 30, 2020-$27.68M-125.4%
Q1 FY2020Mar 31, 2020$9.46M–
Q4 FY2019Dec 31, 2019-$19.58M–
Q3 FY2019Sep 30, 2019-$6.48M–
Q2 FY2019Jun 30, 2019$109.16M–
Q1 FY2019Mar 31, 2019-$18.73M–
Q4 FY2018Dec 31, 2018-$16.78M–
Q3 FY2018Sep 30, 2018-$10.31M–
Q2 FY2018Jun 30, 2018-$28.42M–
Q1 FY2018Mar 31, 2018-$24.25M–
Q4 FY2017Dec 31, 2017-$6.67M–
Q3 FY2017Sep 30, 2017-$3.51M-102.6%
Q2 FY2017Jun 30, 2017-$12.88M–
Q1 FY2017Mar 31, 2017-$10.55M–
Q4 FY2016Dec 31, 2016-$15.17M–
Q3 FY2016Sep 30, 2016$134.07M–

More Xencor figures

See a number that looks wrong?